Clinical trials
Glaucoma clinical trials
Below are recruiting glaucoma clinical trials, each written for real people, not researchers. We’re tracking 201 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06693882Enrolling by invitation
Electrical stimulation for glaucoma
This study tests if mild electrical stimulation of the optic nerve can help people with moderate to advanced glaucoma. It may be an option if your glaucoma has gotten worse despite standard treatments.
San Francisco, CaliforniaAges 18 years+ - NCT06685211Recruiting
Electrical stimulation for vision in glaucoma
This trial tests whether gentle electrical stimulation can help improve vision in people with moderate vision loss from glaucoma. It might offer a new way to strengthen remaining vision.
Palo Alto, CaliforniaAges 18 years+ - NCT06629649Recruiting
AI-based glaucoma screening at health centers
This trial uses an AI tool to screen for glaucoma at community health centers. If you qualify, you will get a free eye check to catch glaucoma early and help researchers improve screening for high-risk groups.
Birmingham, AlabamaAges 18 years+ - NCT06492538Recruiting
Eye changes after glaucoma angle surgery
This study looks at how your eye's drainage angle changes after glaucoma surgery. It helps doctors understand what happens to the front part of your eye after procedures like laser or surgery to open the drainage area.
Guangzhou, GuangdongAges 30–85 - NCT06227299Enrolling by invitation
Long-term study of glaucoma surgeries and lasers
This study follows patients over time to see how well different glaucoma treatments (medications, laser, or surgery) work. It may help doctors learn which treatments are best for managing glaucoma and high eye pressure.
Lausanne, Canton of VaudAges 18 years+ - NCT06124521Recruiting
Community glaucoma support study for Black adults
This study tests a way to help Black adults in Michigan manage glaucoma through a community church program. It’s for those who already had a screening eye exam and want support staying on top of their eye health.
Ann Arbor, MichiganAges 40 years+ - NCT05940623Recruiting
Home eye pressure monitoring for glaucoma
This study tests whether measuring your eye pressure at home with a special device can help control glaucoma and slow its progression. It may offer a more convenient way to track your condition between doctor visits.
Wong Chuk HangAges 18 years+ - NCT05264818Recruiting
Study measures eye surface sugar layer in glaucoma
This study looks at a thin “sugar coating” on the inside surface of the eye (the endothelial glycocalyx) in people with primary open-angle glaucoma and compares it with people without optic nerve disease. The results may help researchers better understand how glaucoma affects the eye.
ParisAges 18 years+ - NCT04635020Recruiting
iStent versus laser for exfoliation glaucoma with cataract
This trial compares two treatment options for people with exfoliation glaucoma who also have cataracts: a tiny implant placed during cataract surgery (iStent) versus laser treatment. It aims to see which approach better controls eye pressure over 12 months and improves outcomes.
HelsinkiAges 50–100 - NCT04651530Recruiting
Endoscopic laser treatment for normal-pressure glaucoma
This study tests an endoscopic laser procedure to lower eye pressure and slow damage in people with normal-tension glaucoma. It may help protect the optic nerve, especially if your glaucoma is stable on drops and you also have a cataract.
HelsinkiAges 55–100 - NCT05401357RecruitingPhase 3
Test eye drops for glaucoma or high eye pressure in both eyes
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
Newport Beach, CaliforniaAges 18 years+ - NCT05340647Recruiting
Study of micro-invasive glaucoma surgery options
This trial studies outcomes after certain minimally invasive glaucoma surgeries, including the Preserflo microshunt. It may help improve how safely and effectively glaucoma surgery is done, and how patients are followed afterward.
OsloAges 18 years+ - NCT05844384Recruiting
Testing a new eye drop bottle for glaucoma
This study checks whether a device called the Nanodropper helps deliver glaucoma medicine as well as standard use. It is for adults with stable primary open-angle glaucoma (or ocular hypertension) who are on a limited number of eye-pressure medicines.
Lackland Air Force Base, TexasAges 18 years+ - NCT05275738Recruiting
Nicotinamide treatment for glaucoma progression
This trial studies whether nicotinamide (a form of vitamin B3/niacin) can slow or affect glaucoma progression. You may be eligible if you have newly diagnosed, untreated glaucoma or if you have treated glaucoma with measurable visual field changes.
StockholmAges 18 years+ - NCT06057051Recruiting
Stent implant for mild to moderate open-angle glaucoma
This trial studies a tiny implant called iStent Infinite that helps drain fluid from the eye to lower pressure in people with mild to moderate open-angle glaucoma. It may offer a new way to manage the condition.
Cincinnati, OhioAges 35 years+ - NCT05710198RecruitingPhase 3
Citicoline eye drops to slow vision field loss in glaucoma
This Phase 3 trial tests whether citicoline 2% eye drops can help slow worsening of the visual field in adults with open-angle glaucoma. If you qualify, you would be monitored with repeated eye tests to see if your vision field stays more stable over time.
Milan, MIAges 18 years+ - NCT05371977Recruiting
Deep sclerectomy or trabeculectomy for normal tension glaucoma
This trial compares two types of glaucoma surgery to lower pressure and protect vision in people with normal tension glaucoma. If your glaucoma is not well controlled on drops, you may be considered to help find which surgery works better and more safely.
HelsinkiAges 55–100 - NCT05405868RecruitingPhase 3
Nicotinamide for early to moderate open-angle glaucoma
This trial tests whether nicotinamide (a form of vitamin B3) can slow vision changes from open-angle glaucoma. It compares nicotinamide versus a placebo (inactive pill) in adults with early to moderate disease.
Belfast, Northern IrelandAges 18 years+ - NCT07802769Recruiting
MRI brain scans for people with glaucoma
This study uses MRI scans to look at brain structure in people with glaucoma compared to healthy controls. It aims to understand how glaucoma affects the brain over time, which may help improve future treatments.
BordeauxAges 18 years+ - NCT00286637Recruiting
New tests to diagnose glaucoma and related eye problems
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
Philadelphia, PennsylvaniaAges 18 years+ - NCT04416724Recruiting
Surgery versus laser for early pseudoexfoliation glaucoma
This trial compares cataract surgery (phacoemulsification) versus a laser treatment (SLT) as the first treatment for pseudoexfoliation glaucoma. It aims to find which approach lowers eye pressure and helps prevent progression for people with early disease and cataracts.
Halifax, Nova ScotiaAges 50 years+ - NCT07770685RecruitingPhase 1/Phase 2
Study of a new eye drop for advanced glaucoma
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
Boston, MassachusettsAges 18 years+ - NCT07771699Recruiting
Brain stimulation for balance and thinking in older adults with glaucoma
This study tests a non-invasive brain stimulation technique to see if it can improve balance and thinking in older adults with glaucoma. It involves a series of sessions where a mild electrical current is applied to the brain.
Kowloon, Hong KongAges 55 years+ - NCT07758569Recruiting
AI tool for detecting glaucoma in eye photos
This study is testing an artificial intelligence tool that can automatically detect signs of glaucoma in photos of the retina. It may help confirm that the AI can accurately identify glaucoma, which could lead to faster diagnosis and monitoring for patients.
AlexandroupoliAges 18 years+
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for glaucoma?
- Yes. Clin2 currently lists 201 recruiting glaucoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a glaucoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a glaucoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.